Inpatient prescribing of dual antiplatelet therapy according to the guidelines

Autor: Moerlie, Ashwin R., VAN UDEN, Renate C., Mantel-Teeuwisse, Aukje K., VAN DEN BEMT, Patricia, Becker, Matthijs L., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Pharmacy Practice, Vol 18, Iss 2, p 1803 (2020)
Pharmacy Practice (Granada) v.18 n.2 2020
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
Pharmacy Practice, 18(2). Centro de Investigaciones y Publicaciones Farmaceuticas
Pharmacy practice, 18(2):1803, 1-6. CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS
Pharmacy Practice
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of bleeding. Guidelines on DAPT recommend using this combination for a limi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78caede6d87c5b961b51422d71966f45
https://doi.org/10.18549/PharmPract.2020.2.1803